Global Myositis Market

1. Summary

The Global Myositis Market was valued at $3.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.2% CAGR, to an estimated market size of $4.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global myositis market encompasses the diagnostic services, pharmaceutical treatments, and supportive care for a group of rare autoimmune inflammatory muscle diseases. This includes Inclusion Body Myositis (IBM), Dermatomyositis (DM), Polymyositis (PM), and Immune-Mediated Necrotizing Myopathy (IMNM). The scope covers pharmacotherapy (corticosteroids, immunosuppressants, and biologics), physical therapy, mobility aids, and specialized hospital care, while excluding general musculoskeletal treatments not related to autoimmune inflammation.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Myositis Market in the period 2025-30:

• The market is experiencing a surge in orphan drug designations as pharmaceutical companies target high unmet needs in rare neuromuscular disorders.
• Advancements in Myositis-Specific Autoantibodies (MSAs) testing are significantly reducing diagnostic delays and enabling more accurate disease stratification.
• There is a notable shift from broad-spectrum immunosuppressants toward targeted biologics and personalized therapeutic approaches.
• The geriatric population growth is a primary driver, particularly for Inclusion Body Myositis, which predominantly affects individuals over the age of 50.
• Integration of telemedicine and digital health platforms is improving long-term management and remote monitoring for patients with limited mobility.
• Strategic collaborations between biotech firms and academic research centers are accelerating the development of gene therapies and muscle-strengthening agents.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: